InsidersTradesSigma
泽璟制药: management transactions · France · AMF
SSE:688266FR·AMFMcap 24.5Bn€
Browse the full insider trade history of 泽璟制药, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €24.5bn. The latest transaction was reported on 16 April 2026 (Sale). Among the most active insiders: ZELIN SHENG(盛泽林). Every trade is accessible without an account.
32
Insider Decl.
0
Thresholds
·
31 ops.
Buy Volume
€3m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
98.31 €
Income statement
Revenue810.5 M€
Gross profit732.9 M€90% margin
Net income−162.9 M€-20.1% margin
Balance sheet & cash
Market cap24.54 Bn€
Total debt1.13 Bn€
Free Cash Flow−210.2 M€
Last declaration on 16 April 2026
Declarations0 total
No declarations found
0 of 0 declarations
About 泽璟制药
Zai Lab is a company focused on developing innovative medicines, particularly in oncology. It is listed on the Shanghai Stock Exchange.